Plexium
6 known investors
Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.
Founders & leadership
MM
Michael Martin, Ph.D.Chief Executive Officer, President
JF
Jorge F. DiMartino
MM
Michael MartinPresident, Chief Executive Officer
MG
Mike GreyinExecutive Chairman